Browse studies

Find your next paid study

1 recruiting study matching your filters

Phase I, Open-Label Study of Dually Armored Chimeric Antigen Receptor (CAR) T Cells (TmPSMA-02) in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

This is a Phase I, open-label dose finding study to assess the safety, tolerability, manufacturing feasibility, and preliminary efficacy of TmPSMA-02 CAR T cel…

Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

University of PennsylvaniaNCT06046040